Ebola vaccine made in UK now ready for trials

• UK-developed Ebola vaccine progresses to human trials, potentially providing another immunisation option against a high-mortality infectious disease
• Clinical trials will generate essential safety and efficacy data to support regulatory approval and future deployment in at-risk populations
• Successful development demonstrates UK pharmaceutical research capacity and could strengthen outbreak response capabilities for future Ebola incidents

A new vaccine to tackle Ebola will now be tested on people.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.